OGB-23502

N/A

Report date: 2024/11/15 19:16:39

Base Information

Drug NameOGB-23502
Drug Alias NameOGB23502
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionProgrammed cell death protein 1 blockersVascular endothelial growth factor inhibitors
TargetsProgrammed cell death protein 1Vascular endothelial growth factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOnegene Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesOnegene Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A